Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INOVIO PHARMACEUTICALS, INC.

(INO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inovio Pharmaceuticals, Inc.(NasdaqGS:INO) added to Russell Small Cap Comp Value Index

06/25/2021 | 12:00am EDT

Inovio Pharmaceuticals, Inc.(NasdaqGS:INO) added to Russell Small Cap Comp Value Index


ę S&P Capital IQ 2021
All news about INOVIO PHARMACEUTICALS, INC.
09/10INOVIO PHARMACEUTICALS : BofA Securities Downgrades Inovio Pharmaceuticals to Underperform..
MT
09/01INOVIO PHARMACEUTICALS : to Present at Upcoming Investor Conferences in September
PR
08/26INOVIO PHARMACEUTICALS : Receives Authorization From Brazil Regulator to Start Phase 3 Tri..
MT
08/26INOVIO PHARMACEUTICALS : Receives Authorization to Conduct Phase 3 Efficacy Trial of its C..
PR
08/26INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its Covid-19 DNA Vac..
CI
08/09INOVIO PHARMACEUTICALS : focused on launching global COVID-19 vaccine trial next month - C..
RE
08/09INOVIO PHARMACEUTICALS : focused on launching global COVID-19 vaccine trial next month - C..
RE
08/09INOVIO : Q2 Earnings Snapshot
AQ
08/09INOVIO PHARMACEUTICALS : Reports Narrower Q2 Loss on Higher Revenue
MT
08/09INOVIO PHARMACEUTICALS : Earnings Flash (INO) INOVIO PHARMACEUTICALS Posts Q2 Revenue $272..
MT
More news
Analyst Recommendations on INOVIO PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 4,71 M - -
Net income 2021 -272 M - -
Net Debt 2021 - - -
P/E ratio 2021 -5,99x
Yield 2021 -
Capitalization 1 639 M 1 639 M -
Capi. / Sales 2021 348x
Capi. / Sales 2022 16,6x
Nbr of Employees 262
Free-Float 98,3%
Chart INOVIO PHARMACEUTICALS, INC.
Duration : Period :
Inovio Pharmaceuticals, Inc. Technical Analysis Chart | INO | US45773H2013 | MarketScreener
Technical analysis trends INOVIO PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 7,79 $
Average target price 13,22 $
Spread / Average Target 69,7%
EPS Revisions
Managers and Directors
J. Joseph Kim President, Chief Executive Officer & Director
Peter D. Kies Chief Financial Officer
Simon X. Benito Chairman
Laurent M. Humeau Chief Scientific Officer
Kate E. Broderick Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
INOVIO PHARMACEUTICALS, INC.-11.98%1 639
MODERNA, INC.305.22%170 876
LONZA GROUP AG31.58%59 927
IQVIA HOLDINGS INC.41.30%48 510
CELLTRION, INC.-23.26%31 691
SEAGEN INC.-9.18%28 939